Single Nucleotide Polymorphisms and AMD in Older Women
Principal Investigator
Anne Coleman, MD, PhD
University of California, Los Angeles
Los Angeles, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - March 31, 2009
Grant ID
M2007059
Goals
These experiments seek to determine whether genes related to bone metabolism are associated with risk of AMD
Summary
Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness in persons 65 years of age and older in the developed world. The cause of AMD is not known; however, it is believed that a combination of genetic and environmental factors is responsible for the majority of cases. Therefore, studies involving genes relevant to eye tissues and function, and determining if their effects are modified by the presence of other AMD risk factors such as smoking. This may reveal important information regarding the cause of this important disease. Some of our preliminary research suggests that bone disease and AMD may have common risk factors. Therefore, genes relevant to bone disease and metabolism may be associated with AMD risk. Using data from the Study of Osteoporotic Fractures, the goals of our study are to determine whether variations in 15 genes related to bone metabolism and expressed in eye tissues are associated with incident AMD in women 75 years of age and older and whether genetic effects may be modified by environmental risk factors for AMD such as smoking, nutritional factors, or reproductive hormone exposures.
Related Grants
Macular Degeneration Research
Studying the Role of Genes & the Tone of Our Eye Pigment in AMD
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Ruchi Sharma, PhD
Current Organization
National Eye Institute
Macular Degeneration Research
The Role of Mitochondrial Dysfunction in Age-Related Macular Degeneration
Active Dates
July 01, 2023 - June 30, 2025

Principal Investigator
Navdeep Gogna, PhD
Current Organization
The Jackson Laboratory
Macular Degeneration Research
Machine Learning to Predict AMD-Associated Genetic Variant Impact
Active Dates
July 01, 2022 - June 30, 2025

Principal Investigator
Leah Vandenbosch, PhD
Current Organization
Seattle Children's Hospital